| 000 | 00000nas##2200000za#4500 |
| 001 | 9.514730 |
| 003 | CaOODSP |
| 005 | 20210420084523 |
| 007 | ta |
| 008 | 150406c2000||||xxc|| m #||||f| |0eng|d |
| 040 | |aCaOODSP|beng |
| 043 | |an-cn--- |
| 086 | 1 |aH42-2/3E |
| 110 | 1 |aCanada. |bHealth Products and Food Branch. |
| 245 | 10|aGuidance for industry / |cIssued by the Therapeutic Products Programme. |
| 246 | 3 |aTherapeutic Products Programme guidance document |
| 260 | |aOttawa - Ontario : |bHealth Canada. |
| 563 | |aLoose-leaf |
| 775 | 08|tLigne directrice à l'intention de l'industrie / |w(CaOODSP)9.513090 |
| 776 | 0#|tGuidance for industry |w(CaOODSP)9.506921 |